O Yu-kyung, MFDS Commissioner, Visits Samsung Electronics Semiconductor Plant... "Supporting Digital Medical Device Development"

Panoramic view of Samsung Electronics' Pyeongtaek Line 2 factory, the world's largest semiconductor plant. Photo by Hyunmin Kim kimhyun81@

[Asia Economy Reporter Jo In-kyung] Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety (MFDS), promised to provide policy support for the development of digital medical devices utilizing semiconductors.

The MFDS announced that Commissioner Oh visited Samsung Electronics' Pyeongtaek plant located in Godeok-myeon, Pyeongtaek-si, Gyeonggi-do, on the afternoon of the 5th to observe the semiconductor production site and listen to the voices from the digital healthcare device industry, including semiconductors.

Commissioner Oh's visit was organized to directly examine the use of semiconductors, a core component of the 4th Industrial Revolution, in advanced industries such as medical devices, and to explore policy support measures.

At the site, Commissioner Oh stated, "With the recent shift in the medical paradigm towards prevention and health management, the market for medical devices utilizing semiconductors, such as digital healthcare devices, is rapidly growing. Now is the time for the government and private sector to work tirelessly together to establish a foundation to dominate the global market for semiconductor-based digital medical devices and lead international regulations."

She continued, "Based on scientific knowledge and expertise, while ensuring safety, we will actively pursue regulatory innovation to creatively solve various problems faced by companies on the ground and will spare no policy support to accelerate the revolution of digital healthcare based on innovative semiconductor technologies."

The MFDS recently approved a digital healthcare device app embedded in a smartwatch that can measure blood pressure and electrocardiograms using semiconductors as a software medical device. The semiconductors used in this device convert and analyze biometric signals digitally based on algorithms.

An MFDS official stated, "We will continue to proactively publish clinical trial evaluation guidelines and continuously train regulatory science personnel to ensure that innovative semiconductor-based digital medical devices can dominate the global market."

This content was produced with the assistance of AI translation services.